ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

OD Contract Concepts Okayed

October 17, 1986

Klausner To Revamp NCI Budget Process To Make Categories Mean What They Say

December 8, 1995

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993